Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants (LAIF)

This study has been terminated.
(Primary endpoint showed no stat significant difference. FU > M12 terminated.)
Sponsor:
Information provided by (Responsible Party):
Swedish Orphan Biovitrum
ClinicalTrials.gov Identifier:
NCT01413581
First received: June 8, 2011
Last updated: October 31, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
No publications provided by Swedish Orphan Biovitrum

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):